Advancing Transfusion and Cellular Therapies Worldwide (AABB) recebe inscrições para concorrer a prêmio na área de Hematologia.
The Advancing Transfusion and Cellular Therapies Worldwide (AABB) is an international, not-for-profit association representing individuals and institutions involved in the fields of transfusion medicine and cellular therapies. The association is committed to improving health through the development and delivery of standards, accreditation and educational programs that focus on optimizing patient and donor care and safety. AABB membership includes physicians, nurses, scientists, researchers, administrators, medical technologists and other health care providers. AABB members are located in more than eighty countries and AABB accredits institutions in over fifty countries.
The Tibor Greenwalt Memorial Award and Lectureship honors Tibor Greenwalt, MD, who was the first registrant at the first AABB Annual Meeting and founding editor of "Transfusion." The Award recognizes an individual who made major scientific or clinical contributions to hematology, transfusion medicine or cellular therapies, and succinctly communicated these advances.
Data Limite January 27, 2017.
Elegibilidade Individuals who made major scientific or clinical contributions to hematology, transfusion medicine or cellular therapies, and succinctly communicated these advances.
Premiação Recipient will receive a US$1,000.00 honorarium.
Note: Acceptance of the Award requires attendance at the AABB Annual Meeting and the presentation of a lecture on a current topic of interest.
Fonte As informações descritas acima foram obtidas na homepage da Financiadora.
Para maiores informações, clique aqui